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Abstract
Background: Brazil has many people living with HIV (PLWH) who are unaware of their serostatus. The public health
system has recently added HIV self-testing (HIVST) for key populations such as men who have sex with men (MSM).
This study estimates HIVST acceptability among Brazilian MSM and explores factors associated with acceptability
among MSM who have never tested for HIV or who had a previous negative result.
Methods: Respondent-driven sampling (RDS) was used to recruit 4176 MSM in 12 Brazilian cities in 2016 to this
biological and behavioral surveillance study. We excluded from this analysis all MSM who were aware of their
positive HIV serostatus. Descriptive, bivariate and multivariate analyses were conducted. Overall proportions were
weighted with Gile’s estimator in RDS Analyst software and 95% confidence intervals were calculated. The analyses
of HIVST acceptability were stratified by prior HIV testing (never or one or more times).
Results: For this analysis, 3605 MSM were included. The acceptability of HIVST was 49.1%, lower among those who
had never tested for HIV (42.7%) compared to those who had a previous HIV negative test (50.1%). In the subgroup of
MSM who had never tested for HIV, those who reported discrimination or who had a medical appointment in the last
12months reported higher HIVST acceptability. Among MSM who had a previous negative HIV test, only those
reporting condomless receptive anal sex reported higher HIVST acceptability. In addition, we observed that high levels
of knowledge of HIV/AIDS, taking part in lesbian, gay, bisexual, and transgender nongovernmental organizations (LGBT-
NGO), or complete secondary or incomplete higher undergraduate education reported higher acceptability.
Conclusions: The acceptability of HIVST was low among MSM, especially among those who never tested for HIV.
Given access to HIVST in Brazil, we point to the need for programs that enhance promotion of testing addressed to
MSM.
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Background
Routine testing to detect HIV infection is an important
measure for a combined HIV prevention strategy [1]
since it encompasses three levels of intervention. First, a
biomedical level, since technology is used to detect the
virus and initiate antiretroviral therapy (ART), interrupt-
ing transmission [2]. Second, a behavioral and cultural
level, embedding individual and group decisions to test
in a psycho-social matrix of sex, risk and prevention [3].
Finally, successful testing depends not only on the avail-
ability of the test, but also on overcoming barriers such
as stigma and discrimination when accessing testing ser-
vices [4, 5].
Lack of awareness of HIV status affects access to ART
and consequently produces higher viral loads, a potential
factor for HIV transmission [6]. In many countries, men
who have sex with men (MSM) are disproportionately
affected by HIV/AIDS compared to the general popula-
tion [7].
In Latin America, there are 1.9 million PLWH and
80% of these knew their status in 2018 [8]. It has been
estimated that in Brazil there are 900,000 PLWH and
that approximately 135,000 PLWH are unaware of their
serostatus. This corresponds to 85% of the 90% goal of
the 90–90-90 UNAIDS goals for PLWH [9, 10].
A survey using respondent-driven sampling (RDS)
among MSM in 12 state capitals in 2016 indicated that
Brazilian MSM knowledge of HIV serostatus is low.
Among those who were tested and diagnosticated living
with HIV in this study, 44% had not been aware of their
previous serostatus [11]. A similar RDS study, conducted
in 2009 in 10 cities around the country demonstrated
that almost half (48%) of MSM had never previously
tested for HIV [12]. In a comparison between the 2009
and 2016 surveys, there was a drop in the proportion of
MSM who had never tested, from 49.8% in 2009 to
33.8% in 2016, and an increase in the proportion of
those who tested during the previous 12 months, from
21.2 to 43.3% [13]. In Salvador, a capital city in the
country’s most impoverished region (Northeast), in the
2009 survey, 62.8% of MSM reported they had never
tested for HIV [14]. In Curitiba, a city in a high-income
region (South), in another survey among MSM in 2015,
the proportion never tested was much smaller: 24.3%
[15], demonstrating important geographical disparities in
rates of HIV testing among MSM in Brazil.
In Brazil, free access to HIV test occurs mainly in spe-
cialized services (e.g. testing and counseling centers,
clinics and hospitals). Recently, HIV testing has been
made available in Primary Health Care (PHC) clinics in
the Brazilian National Health System (Sistema Único de
Saúde: SUS) [16]. However, the primary beneficiaries of
this program are pregnant women [17], and coverage
among sexual minorities remains low [18, 19]. Stigma
and discrimination towards MSM in Brazil are high, and
is considered a barrier to HIV testing [20–22]. One op-
tion to respond to this deficit is HIV self-testing (HIVS
T). HIVST has been introduced in many countries, in-
cluding Brazil, following a recommendation from the
World Health Organization in 2016 [23]. HIVST is sim-
ple, easy to use, allows the individual to conduct the test
alone, can use oral fluid or a blood sample, and results
can be interpreted without professional help [23].
HIVST guarantees confidentiality and privacy [24, 25].
By enabling testing outside the health services HIVST
decentralizes testing and strengthens people’s autonomy
[23, 26]. Furthermore, it may facilitate an increase in
testing frequency among individuals at high risk of HIV
infection and in populations groups with less frequency of
testing in traditional services [24]. A meta-analysis showed
that HIVST doubled uptake of testing among men, fre-
quency of testing among MSM, and the likelihood of an
HIV-positive diagnosis [27]. HIVST could also improve
HIV care as it allows for early detection and treatment ini-
tiation [28] and can potentially reduce the spread of HIV
infection through test and treat [2, 29, 30], and increased
HIV risk perception [31].
There are few studies on the acceptability of HIVST in
middle-income countries [25]. In Latin America, an RDS
survey in Argentina showed that 74% of the MSM were
likely to buy an HIVST at a pharmacy for use at home
[32] and a cross-sectional online survey in Brazil among
MSM previously testing HIV negative estimated that
47% reported a preference for an HIVST at home [33].
More recently, two cross-sectional online surveys, car-
ried out on a sample of MSM users of hookup apps from
five Brazilian regions, estimated that HIVST awareness
ranged from 26% in 2016 to 33% in 2017, and willing-
ness to use from 50 to 42%, respectively [34]. Although
these studies have assessed HIVST acceptability among
MSM, few have explored how previous testing affects ac-
ceptability, especially when comparing those who never
tested to those who had a previous negative HIV result.
Both groups could potentially benefit from access to
additional testing services [35]. Moreover, there are no
studies of HIVST acceptability among a large population
sample of Brazilian MSM. Therefore, this article aims to
estimate the acceptability of HIVST among MSM from
12 Brazilian cities and to investigate factors associated
with acceptability among those never tested for HIV or
who had a previous HIV negative result.
Methods
Study location, design, and population
The study is based on data collected in a behavioral and
biological surveillance study entitled “A nationwide
study of the behaviors, attitudes, practices, and preva-
lence of HIV, Syphilis and Hepatitis B and C among
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MSM in Brazil”, conducted from June to December
2016 in 12 state capitals: Manaus and Belém in the
Northern region; Fortaleza, Recife and Salvador, in the
Northeast; Brasília and Campo Grande in the Central-
West; Belo Horizonte, Rio de Janeiro and São Paulo in
the Southeast; and Curitiba and Porto Alegre in the
South.
The sample consisted of men defined as biologically
male, 18 years of age or older, reporting oral sex or anal
intercourse with another man in the previous 12 months;
and living, studying or working in one of the study
cities.
Data collection
RDS methods were used to recruit participants. Before
initiation of the survey, formative qualitative research
using both individual interviews and focus group discus-
sions was conducted to explore participation in the
study, including willingness to recruit, testing, study lo-
gistics, such as level and kind of incentive, siting, and
working hours [36].
To start the recruitment process six MSM were pur-
posively selected in each city. These individuals, known
as seeds, had large social networks of MSM and repre-
sented different sociodemographic characteristics. Next,
each of these seeds invited three other MSM from their
social networks using three invitation coupons. This
procedure was repeated in sequence until the desired
sample size was reached, estimated a priori as 350 par-
ticipants per city. Participants received BRL 25.00 (USD
$7.40) for their participation and for each recruited par-
ticipant (BRL 25.00 for each one up to a total of three
new participants - BRL 100.00) as a means of reimburs-
ing their expenses for transportation and food. Data
were collected using computer assisted personal inter-
views (CAPI) at fixed office sites, where educational ma-
terials, condoms and lube were provided, and where
counseling, blood draws and results were provided. A
total of 4176 MSM were recruited in the 12 cities, who
signed separate consent forms for the interview and for
testing. The Research Ethics Committee of the Federal
University of Ceará approved the research project. Fur-
ther details can be found in Kendall et al. [36].
Study variables
A descriptive analysis was performed for the following
variables: (1) demographic and education: age (< 25 years
and ≥ 25 years), self-declared race (white, black, brown/
mixed race, indigenous/native, Asian origin), schooling
(primary and incomplete secondary education, complete
secondary education, incomplete undergraduate educa-
tion, and complete undergraduate education) and mari-
tal status (single, separated or widowed; married or
living together); (2) socio-economic status with three
categories: A-B for high; C for middle; D-E for low)
based on the Brazilian Economic Classification Criteria
[37]; (3) discrimination: self-reported discrimination due
to sexual orientation during lifetime (yes, no); (4) health
services: medical appointment in the 12 months before
the study (yes, no), having taken part in any workshop
about sexually transmitted infections (STI) and HIV/
AIDS in the 12months before the study (yes, no); and
ever testing for HIV was determined by responses to the
following question: “have you ever been tested for HIV/
AIDS in your life?” (yes, no); (5) knowledge about HIV/
AIDS (low, middle and high) was analyzed according to
item response theory (IRT), measured using 12 items
about transmission and prevention (i.e. there are medi-
cines for HIV-negative people to take to prevent HIV;
an HIV-infected person who is taking AIDS medication
has a lower risk of transmitting the virus, etc.), as de-
scribed in Guimarães et al. [38]; (6) self-perception of
risk (low, middle and high), in response to the question:
“how do you assess your chance of becoming infected
with HIV during your lifetime?”; (7) participation in an
LGBT nongovernmental organization (NGO) (yes, no);
and (8) condomless receptive anal sex in past 6 months
(always used condoms and irregular use of condoms).
The outcome HIVST acceptability (yes, no) was struc-
tured according to the following question: “would you
use an HIV/AIDS diagnosis test that you applied to
yourself?”. The reasons for the decision to use or not use
an HIVST were also collected.
Data analysis
We excluded MSM who were aware of their positive
HIV serostatus before the study, yielding 3605 MSM for
this analysis. The dependence between observations
resulting from recruitment chains in RDS, i.e., the prob-
ability of unequal selection and the different sizes of
each participant’s contact network [39], was taken into
account. Gile’s estimator [40] was used to weigh the pro-
portion estimates with a 95% confidence interval using
RDS Analyst [41]. We aggregated all data from the 12
cities into a single dataset with each city serving as a
stratum.
The weighted data were analyzed using the complex
sample routines in STATA 15 (StataCorp, College Sta-
tion, TX, USA). Descriptive, bivariate analyses were con-
ducted using frequency distributions of the variables of
interest and the differences between the analyzed pro-
portions using Pearson’s χ2 test. All analyses were strati-
fied according to prior HIV testing. i.e., those who were
never tested or those who were tested at least once in a
lifetime and their HIV result was negative. A multivari-
ate logistic regression model was constructed to estimate
the Odds Ratio (OR) with the associated 95% confidence
intervals (CI), as a measure of association between the
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potential associated factors and HIVST acceptability. Se-
lection of variables for multivariate modeling was based
on the bivariate analysis (p-value < 0.15) and the epi-
demiological relevance, taking into account a previous
literature review, concerning potential factors associated
with HIVST acceptability. Those variables with a p-value
of < 0.05 remained in the final model.
Results
Table 1 shows descriptive results by 1) no previous HIV
test and 2) a previous negative HIV result. The following
characteristics did not differ significantly by the two cat-
egories: MSM under 25 years of age (64.3 and 59.5%, re-
spectively), brown/mixed race (48.4 and 39.2%,
respectively), single, separated/widowed (90.1 and 86.1%,
respectively), and reporting protective sex (66.8 and
61.3%, respectively) (p > 0.05). MSM with no previous
HIV test, compared to MSM who had a previous nega-
tive HIV result, had less schooling (46.1% vs 23.5%, p <
0.001), lower socio-economic status (26.5% vs 9.7%, p <
0.001), reported less experience of discrimination during
lifetime (53.1% vs 71.5%, p < 0.001) and had lower HIV
risk perception (24.9% vs 14.6%, p < 0.01). In terms of
health services, the majority of MSM did not engage in
workshops on STI and HIV/AIDS in the last 12 months
in both groups (83.0 and 79.0%, respectively, p > 0.05).
On the other hand, those who never tested reported
fewer medical appointments in the last 12 months
(69.6% vs 87.1%, p < 0.001), lower knowledge about
HIV/AIDS (35.4% vs 24.0%, p < 0.001) and participated
less in LGBT NGO (12.1% vs 19.9%, p = 0.03) than those
who had tested negative.
Overall HIVST acceptability was 47.3% (95% CI: 43.5,
51.1) with reasons given: curiosity (31.3%), as a routine
test (27.8%), easiness (17.8%), they were at risk for HIV
infection (16.6%), and confidentiality (11.3%). And rea-
sons for not using it were: fear (42.7%), did not see why
use it (23.8%), unaware of test availability (2.3%), be-
lieved to be at low or no risk for HIV infection (1.8%)
and because it has never been offered (1.6%) (Table 2).
HIVST acceptability was higher among those who had
a previous negative HIV result (50.1%; 95% CI: 45.3,
54.9), as compared to those with no previous HIV test
(42.7%; 95% CI: 36.3, 49.3), but this did not reach statis-
tically significance (p = 0.07). Regarding reasons for its
use and non-use, respectively, only easiness of the test
(10.7% vs 21.4%, p = 0.01) and fear (50.0% vs 37.8%, p =
0.03) were significantly different when comparing the
two groups (Table 2).
Table 3 shows the bivariate and multivariate analyses
also stratified by testing history. In the multivariate ana-
lysis, among MSM with no previous HIV test, experi-
ence of discrimination (AOR = 2.00, 95% CI: 1.18, 3.38)
and a medical appointment in the last 12 months (AOR
= 1.74, 95% CI: 1.01, 2.99) had a higher odds of HIVST
acceptability. Among MSM who had a previous HIV
negative test, condomless receptive anal sex (AOR =
1.46, 95% CI: 1.00, 2.15) had greater odds of HIVST ac-
ceptability. In addition, in both strata, we observed that
high levels of HIV/AIDS knowledge (AOR = 2.45, 95%
CI: 1.05, 5.70 and AOR = 2.79, 95% CI: 1.58, 4.93), par-
ticipating in an LGBT NGO (AOR = 3.26, 95% CI: 1.29,
8.25 and AOR = 2.06, 95% CI: 1.28, 3.32), and complete
secondary or incomplete undergraduate education (AOR
= 1.74, 95% CI: 1.01, 3.01 and AOR = 2.17, 95% CI: 1.34,
3.51) were associated with greater odds of HIVST
acceptability.
Discussion
The overall acceptability of HIVST was close to 50%, but
it was lower among those with no previous HIV test and
higher among MSM who were better off economically
and better educated (i.e. those with higher level of
schooling and socio-economic status, higher HIV/AIDS
knowledge and who had a medical appointment in the
last 12 months). This may argue that promotion of HIVS
T in Brazil should be more focused on MSM at higher
social vulnerability, that is, MSM with lower levels of
schooling, less HIV/AIDS knowledge and poorer access
to health services.
Figueroa et al. [25], in a systematic review of HIVST
acceptability among key-populations, demonstrated that,
of the 14 studies analyzed, eight indicated high (≥67%),
five moderate (between 34 and 66%), and one low
(≤33%) acceptability of HIVST. Moderate acceptability
found in our study may be due to the date of our field
work in 2016, before HIVST was widely available in
Brazil, either commercially or through the Brazilian Na-
tional Health System (SUS). While the National Health
Surveillance Agency (Agência Nacional de Vigilância
Sanitária: ANVISA) approved the sale of HIVST in
pharmacies in 2015, the first HIVST product was regis-
tered in 2017. The product has been commercially avail-
able since then, in both physical and online drugstores
in all Brazilian states, at a cost of BRL 70.00 (21.90 US$)
or BRL 80.00 (25.00 US$) per kit (7 to 8% of the
monthly minimum wage). It is noteworthy that even
among those willing to use an HIVST, its high cost by
Brazilian standards in the private sector may act as a
barrier and compromise the potential role of this strat-
egy, particularly in low-income settings, thereby justify-
ing free distribution to key and priority populations in
the public sector [42].
Brazil until recently, had a long track record of suc-
cessfully implementing HIV prevention and treatment
interventions through the Brazilian National Health Sys-
tem (SUS) [43–45]. In 2019, Brazil began offering HIVS
T without cost in 14 selected cities and is now
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Table 1 Descriptive analysis of MSM according to no previous HIV test and a previous negative HIV result Brazil, 2016
Variables No previous HIV testa Previous negative HIV resulta p-value
% 95%CI % 95%CI
Age 0.26
< 25 years old 64.3 (57.2–70.9) 59.5 (54.8–64.1)
≥ 25 years old 35.7 (29.1–42.8) 40.5 (35.9–45.2)
Race 0.09
Brown/mixed race 48.4 (41.6–55.2) 39.2 (34.7–43.9)
White 29.1 (22.9–36.2) 34.9 (30.5–39.5)
Black 22.5 (17.9–27.9) 25.9 (21.4–31.2)
Schooling < 0.001
Primary/Incomplete secondary education 46.1 (39.6–52.6) 23.5 (19.9–27.5)
Complete secondary/Incomplete undergraduate education 48.8 (42.4–55.2) 62.6 (58.1–67.0)
Complete undergraduate education 5.2 (2.3–11.5) 13.9 (11.3–17.1)
Socio-economic status groups < 0.001
D-E (Low) 26.5 (21.0–32.8) 9.7 (7.5–12.4)
C (Middle) 38.5 (32.3–45.0) 42.1 (37.4–46.9)
A-B (High) 35.1 (29.1–41.6) 48.2 (43.5–53.0)
Marital status 0.10
Single/separated/widowed 90.1 (85.9–93.2) 86.1 (82.9–88.8)
Married/living together 9.9 (6.8–14.1) 13.9 (11.2–17.1)
Self-reported discrimination during the lifetime < 0.001
No 46.9 (40.5–53.5) 28.5 (24.7–32.7)
Yes 53.1 (46.5–59.5) 71.5 (67.3–75.3)
Medical appointment in the last 12months < 0.001
No 30.4 (25.0–36.4) 12.9 (10.2–16.1)
Yes 69.6 (63.6–75.0) 87.1 (83.8–89.7)
Took part of any workshop on STI and HIV/AIDS in the last 12months 0.26
No 83.0 (76.7–87.9) 79.0 (74.8–82.7)
Yes 17.0 (12.1–23.3) 21.0 (17.3–25.2)
Knowledge about HIV/AIDS (IRT score)2 < 0.001
Low 35.4 (29.4–41.9) 24.0 (19.6–29.1)
Middle 47.6 (41.0–54.2) 47.0 (42.3–51.8)
High 17.1 (12.7–22.6) 29.0 (25.0–33.3)
Self-perception of risk < 0.01
Low 24.9 (19.6–31.0) 14.6 (11.6–18.4)
Middle 60.8 (54.1–67.8) 74.8 (70.2–79.0)
High 14.2 (9.4–20.9) 10.5 (7.7–14.1)
Took part of LGBT NGO 0.03
No 87.9 (81.7–92.2) 80.1 (76.2–83.6)
Yes 12.1 (7.8–18.3) 19.9 (16.5–23.8)
Condomless receptive anal sex (past 6 months) 0.15
Always used condoms 66.8 (60.5–72.4) 61.3 (56.8–65.6)
Irregular use of condoms 33.3 (27.6–39.5) 38.7 (34.4–43.2)
a Weighted by Gile-SS
Magno et al. BMC Infectious Diseases          (2020) 20:865 Page 5 of 10
expanding to other cities. The strategy initially adopted
was the distribution of HIVST in familiar venues for
key-populations and those highly vulnerable to HIV in-
fection [46]. The implementation of free distribution of
HIVST may promote an increase of testing frequency
among high-risk MSM [47]. Moreover, it has been iden-
tified as a cost-effective prevention technology [48, 49].
HIVST has been advanced as a strategy to enhance
testing and contribute to the reduction of HIV transmis-
sion [26, 27, 50]. Our results suggest that the acceptabil-
ity of HIVST is higher precisely among those who have
already tested for HIV, who therefore already have ac-
cess to some form of health service. We believe public
policy for HIV combined prevention should focus on
expanding HIVST to MSM with less access to traditional
health services.
We also found greater acceptability among those
who knew more about HIV/AIDS, took part in an
LGBT NGO and with a recent medical appointment.
This highlights the role of both demand creation
campaigns directed to MSM and support for MSM-
friendly NGO, which unfortunately have been under-
and defunded in the past several years in Brazil [51,
52]. HIVST should be made available with reinforced
HIV/AIDS prevention activities that promote HIVST
within a combined prevention strategy, including
strengthening and extending health services, targeted
health education campaigns and support for
community-based organizations and nongovernmen-
tal organizations (NGO) [53].
Of the MSM we interviewed who had no previous
HIV test, self-reported discrimination was one of the
factors that increased the likelihood of HIVST accept-
ability. As pointed out in the literature, stigma, concerns
about confidentiality and privacy are among the barriers
to testing confronted by MSM [4, 53–55]. Those who
have not yet been tested, or were tested a long time ago,
may resort to HIVST as a strategy to avoid potential dis-
crimination or confidentiality fears in health services.
On the other hand, among MSM who had a previous
HIV negative test, those who reported condomless re-
ceptive anal sex were more likely to accept an HIVST. A
study conducted in Spain showed that MSM reporting
high-risk behaviors had greater intentions to test [56].
“Fear” was reported as the main reason for not using
HIVST. However, “fear” is not limited to HIVST tech-
nology, given that fear is also a barrier to conventional
testing conducted in health services [57]. The fear of
testing is well documented in many population groups,
and amplified here because of the stigma associated with
homosexuality [4, 58, 59]. Furthermore, although our
data do not allow us to explore fear of using HIVST in-
depth, we could argue that it is related to factors found
in other studies. Specifically, in the case of HIVST, the
literature refers to the fear of a positive result without
being properly linked to a health service [54, 58, 60]. As
Flowers et al. suggest, in research conducted with MSM
in the United Kingdom in 2014, HIVST has the potential
to reduce certain barriers related to traditional testing
but may create other complicating factors, such as a
Table 2 Acceptability of HIVST and reasons for use/non-use among MSM according to no previous HIV test and a previous HIV
negative result in 12 Brazilian cities, 2016
Variables Overalla No previous HIV testa Previous negative HIV resulta p-value*
% 95%CI %2 95%CI % 95%CI
Acceptability of HIVST 0.07
Yes 47.3 (43.5–51.1) 42.7 (36.3–49.3) 50.1 (45.3–54.9)
No 52.7 (48.9–56.5) 57.3 (50.7–63.7) 49.9 (45.1–54.7)
Reasons to use HIVST
Curiosity 31.3 (26.7–36.4) 36.8 (27.1–47.7) 28.6 (24.0–33.7) 0.14
As a routine test 27.8 (24.2–31.7) 25.8 (19.2–33.8) 28.8 (24.7–33.4) 0.50
It is more practical/easiness 17.8 (13.6–22.8) 10.7 (6.3–17.5) 21.4 (15.9–28.1) 0.01
Believes to be at risk for HIV infection 16.6 (13.5–20.4) 16.8 (11.0–24.8) 16.6 (13.1–20.8) 0.95
Confidentiality 11.3 (8.5–14.9) 8.9 (6.1–12.8) 12.6 (8.8–17.6) 0.18
Reasons to not use HIVST
Fear 42.7 (37.2–48.3) 50.0 (41.8–58.3) 37.8 (30.8–45.3) 0.03
Does not see any reason to use it 23.8 (20.0–27.9) 24.6 (19.0–31.2) 23.2 (18.3–28.9) 0.73
Unaware of test availability 2.3 (1.6–3.3) 2.5 (1.5–4.4) 2.1 (1.2–3.5) 0.62
Believe to be at low or no risk for HIV infection 1.8 (1.0–3.0) 1.1 (0.5–2.3) 2.2 (1.1–4.4) 0.14
Because it has never been offered 1.6 (1.0–2.6) 1.2 (0.6–2.4) 1.8 (1.0–3.4) 0.39
a Weighted proportion by Gile-SS
* p-value refers to the comparison of proportions between: “no previous HIV test” and “negative previous HIV result”
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Table 3 Acceptability of HIVST among an RDS sample of MSM. stratified by the report of prior HIV testing in 12 Brazilian cities. 2016
Variables No previous HIV test Previous negative HIV result
Bivariate Multivariate Bivariate Multivariate
Wt%a Unadj ORb p-value AdjORc p-value Wt%a Unadj ORb p-value AdjORc p-value
Age
≥ 25 years 34.2 1.00 0.07 48.3 1.00 0.53
< 25 years 48.3 1.79 (0.93–3.45) – – 51.4 1.13 (0.76–1.66) – –
Race
Black 34.6 1.00 0.30 49.9 1.00 0.09
Brown/mixed race 44.5 1.51 (0.83–2.74) – – 44.0 0.78 (0.45–1.36) – –
White 48.6 1.79 (0.86–3.70) – – 57.4 1.35 (0.76–2.40) – –
Schooling 0.01 < 0.001
Primary/Incomplete
secondary education




53.1 2.05 (1.16–3.64) 1.74 (1.01–3.01) 0.04 53.7 2.69 (1.70–4.26) 2.17 (1.34–3.51) < 0.001
Complete undergraduate
education
20.4 0.46 (0.11–1.93) 0.86 (0.27–2.76) 0.81 67.4 4.80 (2.58–8.92) 3.39 (1.75–6.56) < 0.001
Socio-economic status groups
D-E (Low) 32.5 1.00 0.07 27.0 1.00 < 0.001
C (Middle) 40.6 1.41 (0.67–2.96) – – 48.5 2.54 (1.47–4.36) – –
A-B (High) 52.6 2.30 (1.08–4.89) – – 56.1 3.45 (2.02–5.88) – –
Marital status
Married/living together 43.7 1.00 0.91 – – 55.2 1.00 0.33 – –
Single/separated/
widowed
42.6 0.95 (0.42–2.16) – – 49.2 0.78 (0.47–1.28) – –
Self-report of discrimination during the lifetime
No 29.3 1.00 < 0.001 1.00 38.8 1.00 0.001 – –
Yes 54.4 2.87 (1.69–4.87) 2.00 (1.18–3.38) 0.01 54.6 1.89 (1.27–2.82) – –
Medical appointment in the last 12months
No 33.6 1.00 0.01 1.00 48.6 1.00 0.75
Yes 49.9 1.96 (1.12–3.40) 1.74 (1.01–2.99) 0.04 50.7 1.08 (0.64–1.82) – –
Took part of any workshop on STI and HIV/AIDS in the last 12months
No 39.1 1.00 0.03 53.1 1.00 0.03
Yes 58.3 2.17 (1.03–4.57) – – 41.2 0.61 (0.39–0.96) – –
Knowledge about HIV/AIDS (IRT score)d
Low 38.3 1.00 0.06 1.00 31.7 1.00 < 0.001 1
Middle 39.8 1.06 (0.57–1.98) 1.13 (0.66–1.96) 0.64 52.6 2.39 (1.37–4.14) 2.38 (1.44–3.92) < 0.001
High 59.9 2.41 (1.08–5.37) 2.45 (1.05–5.70) 0.04 61.2 3.39 (1.85–6.24) 2.79 (1.58–4.93) < 0.001
Self-perception of risk
Low 38.0 1.00 0.67 37.3 1.00 0.11
Middle 45.9 1.38 (0.72–2.62) – – 51.7 1.79 (0.95–3.37) – –
High 42.6 1.21 (0.40–3.64) – – 56.4 2.17 (0.91–5.15) – –
Took part of LGBT NGO
No 39.5 1.00 0.02 1.00 46.6 1.00 < 0.001 1.00
Yes 65.0 2.84 (1.12–7.17) 3.26 (1.29–8.25) 0.01 64.1 2.04 (1.23–3.39) 2.06 (1.28–3.32) 0.003
Condomless receptive anal sex (past 6months)
Always used condoms 42.5 1.00 0.96 45.1 1.00 0.01 1.00
Irregular use of condoms 42.8 1.01 (0.57–1.76) – – 56.5 1.58 (1.09–2.28) 1.46 (1.00–2.15) 0.049
a Gile-SS weighted proportion of acceptability
b Unadjusted weighted odds ratio of acceptability with 95% confidence limits
c Adjusted weighted odds ratio of acceptability with 95% confidence limits
d Score obtained through Item Response Theory Analysis
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reduction in linkage to health services and health profes-
sionals to follow up test results and care services, and
fewer opportunities for prevention and counseling of
risk behaviors [55].
Our analysis is not without limitations, including se-
lection bias in the networks recruited and interpretation
of results when using RDS. The survey questionnaire did
not allow for more specific questions on HIVST such as
awareness. Moreover, as a cross-sectional study, full
temporal inference is not possible, although some vari-
ables are partially supported when referring to events
that have occurred in the past.
Conclusion
Our data suggest greater acceptability of HIVST pre-
cisely within the group of MSM who had a previous
HIV negative test and were in a less vulnerable social
context. Given the acceptability of HIVST and its
current policy in Brazil, we suggest improvements that
build on our results and expand this strategy especially
to more vulnerable MSM, as well as the development of
a monitoring system capable of incorporating the results
of HIVST and linking MSM to healthcare services. In fu-
ture studies, it is worth examining health care providers
knowledge and acceptance of HIVST, and the dynamics
of recruitment and retention of PLWH into services for
follow-up. The growing availability of HIVST in Brazil-
ian pharmacies and services of the national health sys-
tem may affect an already challenged access-to-
treatment system. Future studies should also explore
price-sensitivity since currently HIVST available in the
commercial sector is too expensive for repeated use (i.e.
after each risky sexual episode) for many MSM.
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